New Treatments for Migraine-Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe

JAMA Intern Med. 2022 Feb 1;182(2):101-102. doi: 10.1001/jamainternmed.2021.7168.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Canada
  • Europe
  • Humans
  • Migraine Disorders* / drug therapy